We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Synthesis and structure-activity relationship studies of 2,3-dihydroimidazo[2,1- a]isoquinoline analogs as antitumor agents.
- Authors
Cheon, Seung; Park, Joon; Jeong, Seon; Chung, Byung-Ho; Choi, Bo-Gil; Cho, Won-Jea; Kang, Boo-Hyon; Lee, Chong-Ock
- Abstract
5-Aryl-2,3-dihydroimidazo[2,1- a]isoquinolines were reported to have strong antitumor activity and one of the derivatives such as 5-[4′-(piperidinomethyl)phenyl]-2,3-dihydroimidazo[2,1- a] isoquinoline (1, SDZ 62–434) was found to be more effective than the clinical cytostatic agent edelfosine (2) in in vitro and in vivo assays. Currently SDZ 62–434 is in clinical trials in Europe. The structure-activity relationship studies of SDZ 62–434 showed that compounds with substitution on ring A were less active than the lead compound. Ring B in SDZ 62–434 was essential for the activity because compounds without B ring had no antitumor activity. Among the 3-arylisoquinolin-1-one derivatives, 3-[4′-(piperidonomethyl)phenyl] substituted analog had no antitumor activity but simple phenyl substituted compound, such as 4, showed the most potent antitumor activity in various human tumor cell lines.
- Publication
Archives of Pharmacal Research, 1997, Vol 20, Issue 2, p138
- ISSN
0253-6269
- Publication type
Article
- DOI
10.1007/BF02974000